Health committee  Mr. Chair, every effort will be made to get information to the committee in a timely fashion, recognizing that we'll need to redact the confidential information, of course.

Health committee  The CanSino—

Health committee  The very first time CanSino was discussed, it was reviewed in a list of the international candidates, and then Dr. Langley indicated that she had—

Health committee  —and she indicated she would recuse herself from any discussion.

Health committee  It wasn't the first priority, and Dr. Kobinger only came to very few meetings—two and a half meetings. Most of the discussion occurred after he stopped appearing at the task force.

Health committee  Thank you very much, Mr. Chair, for the question. I think that active efforts are being looked at now on how we can realize as much transparency as possible while protecting the confidential business information that legal agreements have been entered into to protect. That's und

Health committee  I think that's an excellent question. Transparency, to the degree possible, is obviously the goal we should all be seeking to achieve, though the work of the vaccine task force is not equivalent to the group you've identified in the United States. That is more equivalent to the r

Health committee  It is extremely important that the decision-making around advice given by the task force is made fully aware of potential conflicts of interest and interests generally. The ministers of ISED, health, and procurement are made fully aware of all of the interests relevant to advice

Health committee  The Pfizer doses received by Canada, which are being referred to here, come from European manufacturing centres, not the U.S.

Health committee  I know that every effort is being made by government ministers to get safe and effective vaccines such as the Pfizer vaccine, and the Moderna and now AstraZeneca ones as quickly as possible to Canadians. They're looking at all destinations where that is possible. The current arra

Health committee  No, I think that puts it very well, Joanne. You have drawn a pretty clear distinction between the work that the Canadian Centre for Vaccinology did early in May with CanSino, and then the subsequent work—

Health committee  That's right, Joanne. The IP was owned by CanSino. It was not NRC IP that was involved in the vaccine. CanSino did have access to the HEK-293 cell line, which is very advanced and used by many vaccine companies in the development of the product. However, all of the IP related to